Literature DB >> 33349939

Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease.

Francesco Cavallieri1,2,3, Valérie Fraix1,4, Francesco Bove1,5, Delia Mulas1,5,6, Manuela Tondelli7, Anna Castrioto1,4, Paul Krack8, Sara Meoni1,4, Emmanuelle Schmitt1, Eugénie Lhommée1, Amélie Bichon1, Pierre Pélissier1, Eric Chevrier1, Andrea Kistner1,4, Eric Seigneuret4,9, Stephan Chabardès4,9, Elena Moro1,4.   

Abstract

OBJECTIVE: This study was undertaken to identify preoperative predictive factors of long-term motor outcome in a large cohort of consecutive Parkinson disease (PD) patients with bilateral subthalamic nucleus deep brain stimulation (STN-DBS).
METHODS: All consecutive PD patients who underwent bilateral STN-DBS at the Grenoble University Hospital (France) from 1993 to 2015 were evaluated before surgery, at 1 year (short-term), and in the long term after surgery. All available demographic variables, neuroimaging data, and clinical characteristics were collected. Preoperative predictors of long-term motor outcome were investigated by performing survival and univariate/multivariate Cox regression analyses. Loss of motor benefit from stimulation in the long term was defined as a reduction of less than 25% in the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III scores compared to the baseline off-medication scores. As a secondary objective, potential predictors of short-term motor outcome after STN-DBS were assessed by performing univariate and multivariate linear regression analyses.
RESULTS: In the long-term analyses (mean follow-up = 8.4 ± 6.26 years, median = 10 years, range = 1-17 years), 138 patients were included. Preoperative higher frontal score and off-medication MDS-UPDRS part III scores predicted a better long-term motor response to stimulation, whereas the presence of vascular changes on neuroimaging predicted a worse motor outcome. In 357 patients with available 1-year follow-up, preoperative levodopa response, tremor dominant phenotype, baseline frontal score, and off-medication MDS-UPDRS part III scores predicted the short-term motor outcome.
INTERPRETATION: Frontal lobe dysfunction, disease severity in the off-medication condition, and the presence of vascular changes on neuroimaging represent the main preoperative clinical predictors of long-term motor STN-DBS effects. ANN NEUROL 2021;89:587-597.
© 2020 American Neurological Association.

Entities:  

Mesh:

Year:  2021        PMID: 33349939     DOI: 10.1002/ana.25994

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  Preoperative Levodopa Response and Deep Brain Stimulation Effects on Motor Outcomes in Parkinson's Disease: A Systematic Review.

Authors:  Zhengyu Lin; Chencheng Zhang; Dianyou Li; Bomin Sun
Journal:  Mov Disord Clin Pract       Date:  2021-12-09

2.  Pre-operative cognitive burden as predictor of motor outcome following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.

Authors:  Venus Tang; Xian Lun Zhu; Claire Lau; Anne Chan; Karen Ma; Jonas Yeung; Tom Cheung; Jill Abrigo; David Yuen Chung Chan; Danny Chan; Vincent Mok; Wai Sang Poon
Journal:  Neurol Sci       Date:  2022-09-01       Impact factor: 3.830

3.  Does Motor Symptoms Asymmetry Predict Motor Outcome of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients?

Authors:  Francesco Bove; Francesco Cavallieri; Anna Castrioto; Sara Meoni; Emmanuelle Schmitt; Amélie Bichon; Eugénie Lhommée; Pierre Pélissier; Andrea Kistner; Eric Chevrier; Eric Seigneuret; Stephan Chabardès; Franco Valzania; Valerie Fraix; Elena Moro
Journal:  Front Hum Neurosci       Date:  2022-06-21       Impact factor: 3.473

4.  Subthalamic Nucleus Stimulation in Parkinson's Disease: 5-Year Extension Study of a Randomized Trial.

Authors:  Silje Bjerknes; Mathias Toft; Reidun Brandt; Trine Waage Rygvold; Ane Konglund; Espen Dietrichs; Stein Andersson; Inger Marie Skogseid
Journal:  Mov Disord Clin Pract       Date:  2021-10-18

5.  Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease.

Authors:  Sara Marceglia; Costanza Conti; Oleg Svanidze; Guglielmo Foffani; Andres M Lozano; Elena Moro; Jens Volkmann; Mattia Arlotti; Lorenzo Rossi; Alberto Priori
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

6.  Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulation.

Authors:  Alessandro Zampogna; Francesco Cavallieri; Francesco Bove; Antonio Suppa; Anna Castrioto; Sara Meoni; Pierre Pélissier; Emmanuelle Schmitt; Amélie Bichon; Eugénie Lhommée; Andrea Kistner; Stephan Chabardès; Eric Seigneuret; Valerie Fraix; Elena Moro
Journal:  NPJ Parkinsons Dis       Date:  2022-09-24

7.  Clinical factors and dopamine transporter availability for the prediction of outcomes after globus pallidus deep brain stimulation in Parkinson's disease.

Authors:  Seung Hyun Lee; Mina Kim; Jooyoung Lee; Jae-Woo Kim; Mi Sun Kim; Sungyang Jo; Sang Ryong Jeon; Sun Ju Chung
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

8.  Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease: A Surgicogenomic Approach.

Authors:  Naomi P Visanji; Mahdi Ghani; Eric Yu; Erfan Ghani Kakhki; Christine Sato; Danielle Moreno; Taline Naranian; Yu-Yan Poon; Maryam Abdollahi; Maryam Naghibzadeh; Rajasumi Rajalingam; Andres M Lozano; Suneil K Kalia; Mojgan Hodaie; Melanie Cohn; Marta Statucka; Alexandre Boutet; Gavin J B Elias; Jürgen Germann; Renato Munhoz; Anthony E Lang; Ziv Gan-Or; Ekaterina Rogaeva; Alfonso Fasano
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.